GlassScriptPhysician profile
Christopher L Allen
NPI 1528271434
$12,527.61
in general payments reported to CMS, 2019-2025
23 companies · $2,778 in 2025
The $2,778 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,396 · 2020: $513 · 2021: $756 · 2022: $1,983 · 2023: $4,250 · 2024: $852 · 2025: $2,778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,375 · Food and Beverage: $2,480 · Consulting Fee: $2,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,375.00 |
| Food and Beverage | $2,479.51 |
| Consulting Fee | $2,025.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $9,118.45 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $1,046.21 | 2019-2025 | Merlin@Home, Cardiomems, Portico |
| Boston Scientific Corporation | $371.80 | 2019-2023 | Wolverine Coronary Cutting Balloon |
| Abiomed | $362.18 | 2021-2024 | Impella |
| Medtronic Vascular, INC. | $273.18 | 2019 | |
| Medtronic, INC. | $249.76 | 2021-2025 | Closurefast |
| Penumbra, INC. | $184.60 | 2019 | |
| Novartis Pharmaceuticals Corporation | $163.84 | 2019-2023 | |
| Shockwave Medical, INC | $153.65 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $134.69 | 2019 | |
| Endologix LLC | $128.86 | 2019 | |
| Janssen Pharmaceuticals, INC | $69.86 | 2019-2020 | |
| Pfizer INC. | $56.66 | 2021-2024 | |
| Amgen INC. | $49.73 | 2020-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.70 | 2022-2025 | Lifevest |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $20.84 | 2023 | Kcentra |
| Covidien LP | $19.73 | 2019 | |
| Cardiovascular Systems INC. | $19.70 | 2019 | |
| Biotronik INC. | $17.19 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $16.45 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $14.00 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $13.87 | 2025 | Uptravi, Opsynvi |
| Merck Sharp & Dohme LLC | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.